@thymus
To get a good understanding of how valuable the FTO inhibitor is, check out this post/YouTube video from @Mason14. I thought I had a good understanding until I watched this video and realised I was only scratching the surface.
https://hotcopper.com.au/threads/rac-primer.5627186/page-258?post_id=53320421
RAC has also recently completed a Capital Raise that fully funds a dose escalation trial of Bisantrene in humans for FTO, along with tracking FTO in other trials that are also going to be commenced very soon.
Due to the funds from the CR, this means RAC will have a lot of clinical data to shop to Pharma in a relatively short period from now (say 3-9 months) in relation to the efficacy of Bisantrene as an FTO inhibitor.
The opportunity here is massive!
Medical / Clinical Discussions, page-469
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.66 |
Change
-0.020(1.19%) |
Mkt cap ! $282.8M | |||
| Open | High | Low | Value | Volume |
| $1.67 | $1.67 | $1.61 | $153.5K | 94.75K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $1.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.67 | 4080 | 1 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |